There are 2789 resources available
173P - What to expect from NCCN BRCA testing criteria: A retrospective cohort analysis
Presenter: Burak Aktas
Session: ePoster Display
174P - Better survival associated with successful vitamin D supplementation in non-metastatic breast cancer survivors
Presenter: Elif Isbilen
Session: ePoster Display
175P - Prosigna test for early breast cancer patients in real-life
Presenter: Delphine Hequet
Session: ePoster Display
176P - Pathological complete response to neoadjuvant systemic therapy in 1160 initial and locally advanced breast cancer patients: Real life data on outcomes
Presenter: Monique Tavares
Session: ePoster Display
Resources:
Abstract
177P - Pathogenicity reclassification of unknown significance variants related to early-onset breast cancer women of mongoloid origin
Presenter: Polina Gervas
Session: ePoster Display
178P - Age-related mutational landscape of luminal breast cancers
Presenter: Nawale Hajjaji
Session: ePoster Display
179P - Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin for early triple-negative breast cancer: A single-arm, open-label, phase II study
Presenter: Chengzheng Wang
Session: ePoster Display
79P - SETD2 a potential tissue-agnostic predictive biomarker for ICIs in solid tumors
Presenter: Yu Chen
Session: ePoster Display
80P - Blood tumor mutational burden (bTMB) and efficacy of immune checkpoint inhibitors (ICIs) in advanced solid tumors: SCRUM-Japan MONSTAR-SCREEN
Presenter: Mishima Saori
Session: ePoster Display
132P - Health economic properties of palbociclib in breast cancer patients with high risk of relapse following neoadjuvant therapy: Results from the Penelope-B trial
Presenter: Katya Galactionova
Session: ePoster Display